Anti-il-36r antibodies for the treatment of atopic dermatitis
AssigneeBoehringer Ingelheim International GmbH
InventorsMary Ruth FLACK, Jay FINE, Janine LAMAR, Steven John PADULA, Chandrasena Reddy PAMULAPATI, Meera RAMANUJAM, Ralf SIGMUND, Sudha VISVANATHAN, Elizabeta ZOVKO
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for treating, preventing or ameliorating atopic dermatitis (AtD). In certain embodiments, the invention provides methods to reduce skin infection in a patient with atopic dermatitis. The methods of the present invention include administering to a patient in need thereof a pharmaceutical composition including an anti-interleukin-36 receptor (anit-IL-36R) antibody.
Claims10
A method for treating atopic dermatitis (AtD) in a subject, comprising administering to the subject a dosage regimen of an anti-interleukin-36 receptor (anti-IL-36R) antibody.
Dependencies are inferred from the claim text.